BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36927626)

  • 41. Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007.
    Seaberg EC; Wiley D; Martínez-Maza O; Chmiel JS; Kingsley L; Tang Y; Margolick JB; Jacobson LP;
    Cancer; 2010 Dec; 116(23):5507-16. PubMed ID: 20672354
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals. Multicenter AIDS Cohort Study.
    Jacobson LP; Yamashita TE; Detels R; Margolick JB; Chmiel JS; Kingsley LA; Melnick S; Muñoz A
    J Acquir Immune Defic Syndr; 1999 Aug; 21 Suppl 1():S34-41. PubMed ID: 10430217
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical characteristics and outcomes of HIV positive patients with lymphoma in an oncological reference center in Mexico City.
    Cardenas-Ortega A; Ramírez-Ibarguen AF; Rivera-Buendía F; Pérez-Jiménez C; Volkow-Fernández P; Martin-Onraet A
    Medicine (Baltimore); 2020 Oct; 99(40):e22408. PubMed ID: 33019417
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy.
    Molina A; Krishnan AY; Nademanee A; Zabner R; Sniecinski I; Zaia J; Forman SJ
    Cancer; 2000 Aug; 89(3):680-9. PubMed ID: 10931469
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients: A Cohort Study.
    Wang Q; De Luca A; Smith C; Zangerle R; Sambatakou H; Bonnet F; Smit C; Schommers P; Thornton A; Berenguer J; Peters L; Spagnuolo V; Ammassari A; Antinori A; Quiros-Roldan E; Mussini C; Miro JM; Konopnicki D; Fehr J; Campbell MA; Termote M; Bucher HC;
    Ann Intern Med; 2017 Jan; 166(1):9-17. PubMed ID: 27750294
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mosaic loss of the Y chromosome and men's health.
    Fukami M; Miyado M
    Reprod Med Biol; 2022; 21(1):e12445. PubMed ID: 35386373
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-Hodgkin lymphoma risk in adults living with HIV across five continents.
    AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord
    AIDS; 2018 Nov; 32(18):2777-2786. PubMed ID: 30234606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
    Milano AF
    J Insur Med; 2023 Jul; 50(1):1-35. PubMed ID: 37725503
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In silico analyses reveal common cellular pathways affected by loss of heterozygosity (LOH) events in the lymphomagenesis of Non-Hodgkin's lymphoma (NHL).
    Aya-Bonilla C; Camilleri E; Haupt LM; Lea R; Gandhi MK; Griffiths LR
    BMC Genomics; 2014 May; 15(1):390. PubMed ID: 24885312
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HMG-CoA reductase inhibitors (statins) use and risk of non-Hodgkin lymphoma in HIV-positive persons.
    Chao C; Xu L; Abrams DI; Towner WJ; Horberg MA; Leyden WA; Silverberg MJ
    AIDS; 2011 Sep; 25(14):1771-7. PubMed ID: 21681055
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998.
    Eltom MA; Jemal A; Mbulaiteye SM; Devesa SS; Biggar RJ
    J Natl Cancer Inst; 2002 Aug; 94(16):1204-10. PubMed ID: 12189223
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hematopoietic mosaic chromosomal alterations increase the risk for diverse types of infection.
    Zekavat SM; Lin SH; Bick AG; Liu A; Paruchuri K; Wang C; Uddin MM; Ye Y; Yu Z; Liu X; Kamatani Y; Bhattacharya R; Pirruccello JP; Pampana A; Loh PR; Kohli P; McCarroll SA; Kiryluk K; Neale B; Ionita-Laza I; Engels EA; Brown DW; Smoller JW; Green R; Karlson EW; Lebo M; Ellinor PT; Weiss ST; Daly MJ; ; ; Terao C; Zhao H; Ebert BL; Reilly MP; Ganna A; Machiela MJ; Genovese G; Natarajan P
    Nat Med; 2021 Jun; 27(6):1012-1024. PubMed ID: 34099924
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HIV viremia and incidence of non-Hodgkin lymphoma in patients successfully treated with antiretroviral therapy.
    Achenbach CJ; Buchanan AL; Cole SR; Hou L; Mugavero MJ; Crane HM; Moore RD; Haubrich RH; Gopal S; Eron JJ; Hunt PW; Rodriguez B; Mayer K; Saag MS; Kitahata MM;
    Clin Infect Dis; 2014 Jun; 58(11):1599-606. PubMed ID: 24523217
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease.
    Oksenhendler E; Boulanger E; Galicier L; Du MQ; Dupin N; Diss TC; Hamoudi R; Daniel MT; Agbalika F; Boshoff C; Clauvel JP; Isaacson PG; Meignin V
    Blood; 2002 Apr; 99(7):2331-6. PubMed ID: 11895764
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum microRNAs in HIV-infected individuals as pre-diagnosis biomarkers for AIDS-NHL.
    Thapa DR; Hussain SK; Tran WC; Dʼsouza G; Bream JH; Achenback CJ; Ayyavoo V; Detels R; Martínez-Maza O
    J Acquir Immune Defic Syndr; 2014 Jun; 66(2):229-37. PubMed ID: 24675587
    [TBL] [Abstract][Full Text] [Related]  

  • 56. B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS.
    Grulich AE; Wan X; Law MG; Milliken ST; Lewis CR; Garsia RJ; Gold J; Finlayson RJ; Cooper DA; Kaldor JM
    AIDS; 2000 Jan; 14(2):133-40. PubMed ID: 10708283
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-resolution loss of heterozygosity screening implicates PTPRJ as a potential tumor suppressor gene that affects susceptibility to Non-Hodgkin's lymphoma.
    Aya-Bonilla C; Green MR; Camilleri E; Benton M; Keane C; Marlton P; Lea R; Gandhi MK; Griffiths LR
    Genes Chromosomes Cancer; 2013 May; 52(5):467-79. PubMed ID: 23341091
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy.
    Kirk O; Pedersen C; Cozzi-Lepri A; Antunes F; Miller V; Gatell JM; Katlama C; Lazzarin A; Skinhøj P; Barton SE;
    Blood; 2001 Dec; 98(12):3406-12. PubMed ID: 11719381
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characteristics of indolent non-Hodgkin lymphoma in patients with type 1 human immunodeficiency virus infection.
    Levine AM; Sadeghi S; Espina B; Tulpule A; Nathwani B
    Cancer; 2002 Mar; 94(5):1500-6. PubMed ID: 11920507
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changing incidence of AIDS-related Kaposi sarcoma and non-Hodgkin lymphoma in Ontario, Canada.
    Bahl S; Theis B; Nishri D; Marrett LD
    Cancer Causes Control; 2008 Dec; 19(10):1251-8. PubMed ID: 18618279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.